Johnson & Johnson stock steadies on its health care scale

Johnson & Johnson (ISIN US4781601046) is a large-cap health care company listed on the New York Stock Exchange and organized around pharmaceuticals, medical technology, and consumer health. Its broad mix gives the stock a more defensive profile than many single-product drugmakers.

Business mix

The company operates through Innovative Medicine and MedTech, with well-known brands and therapies spanning oncology, immunology, surgery, and orthopedics. That structure matters for investors because revenue is spread across several businesses rather than tied to one launch cycle.

Market context

Johnson & Johnson is a member of the S&P 500, which gives the stock a clear US-market anchor and places it alongside the largest publicly traded companies in the country. For portfolio construction, that index membership often signals a stable blue-chip name rather than a narrow trade.

MedTech scale

One representative product area is the company’s medical technology franchise, which includes surgical tools, orthopedics, and cardiovascular devices. That segment adds a second earnings engine next to drugs and helps explain why Johnson & Johnson often trades as a diversified health care bellwether.

Stock snapshot

Johnson & Johnson shares trade on the New York Stock Exchange in USD and remain a closely followed S&P 500 constituent. As of July 15, 2026, 6:44 a.m. UTC, a live market quote was not available in the provided search results.